Identification of novel signalling roles and targets for Gá and Gβã downstream of the insulin-like growth factor 1 receptor in vascular smooth muscle cells

Biochemical Journal

Volumn 450, Issue 1, 2013, Pages 209-219

  Perrault, Raissa ^a   Zahradka, Peter ^a  

^a not available

Author keywords

G protein signalling; Growth factor; Insulin like growth factor 1 receptor (IGF 1R); Receptor signalling; Smooth muscle; Vascular disease

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; IMMUNOPRECIPITATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 84873047898     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20112158     Document Type: Article

References (51)

1. Owens, G. K. (1995) Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75, 487-517
2. Krauss, G. (2004) Signal transmission via transmembrane receptors with tyrosine-specific protein kinase activity. In Biochemistry of Signal Transduction and Regulation (Krauss, G., ed.), pp. 311-354, Wiley, Germany
3. Chitnis, M. M., Yuen, J. S., Protheroe, A. S., Pollak, M. and Macaulay, V. M. (2008) The type 1 insulin-like growth factor receptor pathway. Clin. Cancer Res. 14, 6364-6370
4. Yau, L., Lukes, H., McDiarmid, H., Werner, J. and Zahradka, P. (1999) Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation. Eur. J. Biochem. 266, 1147-1157
5. Girnita, L., Shenoy, S. K., Sehat, B., Vasilcanu, R., Vasilcanu, D., Girnita, A., Lefkowitz, R. J. and Larsson, O. (2007) β-Arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression. J. Biol. Chem. 282, 11329-11338
6. Nishimoto, I., Ogata, E. and Kojima, I. (1987) Pertussis toxin inhibits the action of insulin-like growth factor-I. Biochem. Biophys. Res. Commun. 148, 403-411
7. Poiraudeau, S., Lieberherr, M., Kergosie, N. and Corvol, M. T. (1997) Different mechanisms are involved in intracellular calcium increase by insulin-like growth factors 1 and 2 in articular chondrocytes: voltage-gated calcium channels, and/or phospholipase C coupled to a pertussis-sensitive G-protein. J. Cell. Biochem. 64, 414-422
8. Uehara, T., Tokumitsu, Y. and Nomura, Y. (1999) Pertussis toxin-sensitive and insensitive intracellular signalling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of the Ras mitogen-activated protein kinase cascade. Eur. J. Biochem. 259, 801-808
9. Luttrell, L. M., van Biesen, T., Hawes, B. E., Koch, W. J., Touhara, K. and Lefkowitz, R. J. (1995) Gßy subunits mediate mitogen-activated protein kinase activation by the tyrosine kinase insulin-like growth factor 1 receptor. J. Biol. Chem. 270, 16495-16498
10. ßr subunits upon receptor activation. J. Biol. Chem. 275, 2255-2258
11. Dalle, S., Ricketts, W., Imamura, T., Vollenweider, P. and Olefsky, J. M. (2001) Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J. Biol. Chem. 276, 15688-15695
12. Kuemmerle, J. F. and Murthy, K. S. (2001) Coupling of the insulin-like growth factor-I receptor tyrosine kinase to Gi2 in human intestinal smooth muscle: G^y-dependent mitogen-activated protein kinase activation and growth. J. Biol. Chem. 276, 7187-7194
13. Perrault, R., Wright, B., Storie, B., Hatherell, A. and Zahradka, P. (2011) Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor. Cell. Signalling 23, 739-746
14. Saward, L. and Zahradka, P. (1997) Coronary artery smooth muscle in culture: migration of heterogeneous cell populations from vessel wall. Mol. Cell. Biochem. 176, 53-59
15. Saward, L. and Zahradka, P. (1997) Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ. Res. 81, 249-257
16. McLellan, T. (1982) Electrophoresis buffers for polyacrylamide gels at various pH. Anal. Biochem. 126, 94-99
17. Lehmann, D. M., Seneviratne, A. M. and Smrcka, A. V. (2008) Small molecule disruption of G protein ßy subunit signaling inhibits neutrophil chemotaxis and inflammation. Mol. Pharmacol. 73, 410-418
18. Parrizas, M., Gazit, A., Levitzki, A., Wertheimer, E. and LeRoith, D. (1997) Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 138, 1427-1433
19. Vlahos, C. J., Matter, W. F., Hui, K. Y and Brown, R. F. (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl- 4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241-5248
20. Kanzaki, M., Lindorfer, M. A., Garrison, J. C. and Kojima, I. (1997) Activation of the calcium-permeable cation channel CD20 by a subunits of the Gi protein. J. Biol. Chem. 272, 14733-14739
21. Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C. M., Gerard, N. P., Gerard, C. and Lefkowitz, R. J. (2010)/3-Arrestin-but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc. Natl. Acad. Sci. U.S.A. 107, 628-632
22. Davies, M. G., Mason, D. P., Tran, P. K, Deou, J., Hawkins, S. and Clowes, A. W. (2001) G-protein expression and intimal hyperplasia after arterial injury: a role for Gai proteins. J. Vasc. Surg. 33, 408-418
23. Mintun, M. A., Raichle, M. E., Kilbourn, M. R., Wooten, G. F. and Welch, M. J. (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann. Neurol. 15, 217-227
24. Sugita, T, Yoshikawa, T, Mukai, Y, Yamanada, N., Imai, S., Nagano, K, Yoshida, Y, Shibata, H., Yoshioka, Y, Nakagawa, S. et al. (2008) Comparative study on transduction and toxicity of protein transduction domains. Br. J. Pharmacol. 153, 1143-1152
25. Viv̀es, E. and Lebleu, B. (2002) The tat-derived cell-penetrating peptide. In Cell-Penetrating Peptide: Processes and Applications (Langel, Ü., ed.), pp. 3-20, CRC-Press, U.S.A.
26. Gilchrist, A., Bunemann, M., Li, A., Hosey, M. M. and Hamm, H. E. (1999) A dominant-negative strategy for studying roles of G proteins in vivo.J. Biol. Chem. 274, 6610-6616
27. Fawell, S., Seery, J., Daikh, Y, Moore, C, Chen, L. L, Pepinsky B. and Barsoum, J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 91, 664-668
28. Han, J. S., Kim, K. and Lee, M. (2009) A high mobility group B-1 box A peptide combined with an artery wall binding peptide targets delivery of nucleic acids to smooth muscle cells. J. Cell. Biochem. 107, 163-170
29. Bouallegue, A., Vardatsikos, G. and Srivastava, A. K. (2009) Role of insulin-like growth factor 1 receptor and c-src in endothelin-1-and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 87, 1009-1018
30. Engberding, N., San Martin, A., Martin-Garrido, A., Koga, M., Pounkova, L, Lyons, E, Lassegue, B. and Griendling, K. K. (2009) Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 29, 408-415
31. Li, M., Chiu, J. F, Gagne, J. and Fukagawa, N. K. (2008) Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells. J. Cell. Physiol. 217, 377-387
32. Lodish, H., Berk, A., Zipursky S. L, Matsudaira, P., Baltimore, D. and Darnel, J. (2000) Section 20.4: Receptor tyrosine kinases and Ras. In Molecular Cell Biology (Anonymous), W.H. Freeman, New York
33. McCudden, C. R., Hains, M. D., Kimple, R. J., Siderovski, D. P. and Willard, F S. (2005) G-protein signaling: back to the future. Cell Mol. Life Sci. 62, 551-577
34. Yamauchi, J., Nagao, M., Kaziro, Y andItoh, H. (1997) Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gjöy andGœq/11 subunits. J. Biol. Chem. 272, 27771-27777
35. Crespo, P., Xu, N., Simonds, W. F and Gutkind, J. S. (1994) Ras-dependent activation of MAP kinase pathway mediated by G-protein joy subunits. Nature 369, 418-420
36. Coso, O.A., Teramoto, H., Simonds, W. F and Gutkind, J. S. (1996) Signaling from G protein-coupled receptors to c-jun kinase involves ßy subunits of heterotrimeric G proteins acting on a ras and Rac1-dependent pathway. J. Biol. Chem. 271, 3963-3966
37. Marty, C. and Ye, R. D. (2010) Heterotrimeric G protein signaling outside the realm of 7TM receptors. Mol. Pharmacol. 78, 12-18
38. Patel, T. B. (2004) Single transmembrane spanning heterotrimeric G protein-coupled receptors and their signaling cascades. Pharmacol. Rev. 56, 371-385
39. Camirand, A., Zakikhani, M., Young, F and Pollak, M. (2005) Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (iressa) in human breast cancer cells. Breast Cancer Res. 7, R570-R579
40. Stromberg, T., Ekman, S., Girnita, L, Dimberg, L Y, Larsson, O., Axelson, M., Lennartsson, J., Hellman, U., Carlson, K., Osterborg, A. et al. (2006) IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosisin multiple myeloma cells. Blood 107, 669-678
41. q acts as an adaptor protein in protein kinase Cf (PKCf)-mediated ERK5 activation by G protein-coupled receptors (GPCR). J. Biol. Chem. 285, 13480-13489
42. Sehat, B., Andersson, S., Vasilcanu, R., Girnita, L. and Larsson, O. (2007) Role of ubiquitination in IGF-1 receptor signaling and degradation. PLoS ONE 2, e340
43. Sieg, D. J., Hauck, C. R., Ilic, D., Klingbeil, C. K., Schaefer, E, Damsky C. H. and Schlaepfer, D. D. (2000) FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2, 249-256
44. Garcia-Sainz, J. A., Romero-Avila, M. T. and Medina Ldel, C. (2010) Dissecting how receptor tyrosine kinases modulate G protein-coupled receptor function. Eur. J. Pharmacol. 648, 1-5
45. Gudermann, T, Kalkbrenner, F. and Schultz, G. (1996) Diversity and selectivity of receptor-G protein interaction. Annu. Rev. Pharmacol. Toxicol. 36, 429-459
46. Iaccarino, G., Smithwick, L. A., Lefkowitz, R. J. and Koch, W. J. (1999) Targeting Gßy signaling in arterial vascular smooth muscle proliferation: a novel strategy to limit restenosis. Proc. Natl. Acad. Sci. U.S.A. 96, 3945-3950
47. Rommel, C, Bodine, S. C, Clarke, B. A., Rossman, R., Nunez, L, Stitt, T. N., Yancopoulos, G. D. and Glass, D. J. (2001) Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 3, 1009-1013
48. Burgos, S. A. and Cant, J. P. (2010) IGF-1 stimulates protein synthesis by enhanced signaling through mTORC1 in bovine mammary epithelial cells. Domest. Anim. Endocrinol. 38, 211-221
49. Liu, L, Li, F, Cardelli, J. A., Martin, K. A., Blenis, J. and Huang, S. (2006) Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Oncogene 25, 7029-7040
50. Coppola, D., Ferber, A., Miura, M., Sell, C, D'Ambrosio, C, Rubin, R. and Baserga, R. (1994) A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell. Biol. 14, 4588-4595
51. Preuss, U., Landsberg, G. and Scheidtmann, K. H. (2003) Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase. Nucleic Acids Res. 31, 878-885